New Drug Slows Rare, Debilitating Genetic Disease in Trials
National Institutes of Health
The NIH-supported clinical trial could lead to the first effective treatment for ACDC disease
Innovative approach integrates genetic data to identify drug targets with high potential for clinical trial success
Vamorolone offers a new treatment option with fewer side effects